Review: taking Tegretol and Weed together


Summary

Drug interactions are reported among people who take Tegretol and Weed together. This review analyzes the effectiveness and drug interactions between Tegretol and Weed. It is created by eHealthMe based on reports of 30 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Tegretol

Tegretol has active ingredients of carbamazepine. It is often used in epilepsy. (latest outcomes from Tegretol 31,727 users)

Weed

Weed has active ingredients of marijuana. It is often used in depression. (latest outcomes from Weed 33 users)

On Sep, 16, 2016

30 people who take Tegretol, Weed are studied.


Number of reports submitted per year:

Tegretol and Weed drug interactions.

Drug effectiveness over time:

Tegretol:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Weed:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (2 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (3 of 3 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Tegretol:
  • female: 25.0% - (1 of 4 people)
  • male: 0.0% - (0 of 0 people)
Weed:
  • female: 100.0% - (5 of 5 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Tegretol:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 3 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Weed:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (2 of 2 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 100.0% - (3 of 3 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

1 - 6 months:
  • radiculitis
  • chorioamnionitis
  • placental infarction
6 - 12 months:
  • decreased appetite
  • early satiety
  • gastroparesis
  • vomiting
1 - 2 years:
  • decreased appetite
  • early satiety
  • gastroparesis
  • vomiting
not specified:
  • international normalised ratio increased
  • aggression
  • completed suicide
  • homicide
  • psychotic disorder
  • gastrointestinal haemorrhage
  • acute psychosis
  • cardiac arrest
  • contusion
  • delusion

Most common drug interactions by gender *:

female:
  • arthralgia
  • cerebrovascular accident
  • chorioamnionitis
  • convulsion
  • decreased appetite
  • diabetes mellitus
  • diabetes mellitus inadequate control
  • diabetic foot
  • diabetic ketoacidosis
  • diabetic nephropathy
male:
  • international normalised ratio increased
  • aggression
  • completed suicide
  • homicide
  • psychotic disorder
  • gastrointestinal haemorrhage
  • acute psychosis
  • cardiac arrest
  • contusion
  • delusion

Most common drug interactions by age *:

20-29:
  • aggression
  • homicide
  • delusion
  • loss of consciousness
  • paranoia
  • postictal psychosis
  • abnormal behaviour
  • affective disorder
  • agitation
  • alcohol use
30-39:
  • acute psychosis
  • drug ineffective
  • mania
  • metabolic disorder
  • psychotic disorder
  • chorioamnionitis
  • drug abuse
  • foetal exposure during pregnancy
  • genotype drug resistance test positive
  • oedema
40-49:
  • cardiac arrest
  • completed suicide
  • multiple drug overdose intentional
  • respiratory arrest
  • accidental death
  • blood glucose abnormal
  • decreased appetite
  • diabetes mellitus
  • diabetes mellitus inadequate control
  • diabetic foot
50-59:
  • epistaxis
  • syncope
  • abdominal distension
  • abdominal pain upper
  • cerebrovascular accident
  • convulsion
  • depression
  • international normalised ratio increased
  • gastrointestinal haemorrhage
  • contusion

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Tegretol and Weed?

Can you answer these questions?

More questions for: Tegretol, Weed

You may be interested in these reviews

More reviews for: Tegretol, Weed

On eHealthMe, Tegretol (carbamazepine) is often used to treat epilepsy. Weed (marijuana) is often used to treat depression. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.